Publication: Chemoprevention of cancer: current evidence and future prospects
Open/View Files
Date
2015
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
F1000Research
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Benetou, Vassiliki, Areti Lagiou, and Pagona Lagiou. 2015. “Chemoprevention of cancer: current evidence and future prospects.” F1000Research 4 (F1000 Faculty Rev): 916. doi:10.12688/f1000research.6684.1. http://dx.doi.org/10.12688/f1000research.6684.1.
Research Data
Abstract
Cancer chemoprevention refers to the use of agents for the inhibition, delay, or reversal of carcinogenesis before invasion. In the present review, agents examined in the context of cancer chemoprevention are classified in four major categories—hormonal, medications, diet-related agents, and vaccines—and the main representatives of each category are presented. Although there are serious constraints in the documentation of effectiveness of chemopreventive agents, mainly stemming from the long latency of the condition they are addressing and the frequent lack of intermediate biomarkers, there is little disagreement about the role of aspirin, whereas a diet rich in vegetables and fruits appears to convey more protection than individual micronutrients. Among categories of cancer chemopreventive agents, hormonal ones and vaccines might hold more promise for the future. Also, the identification of individuals who would benefit most from chemopreventive interventions on the basis of their genetic profiles could open new prospects for cancer chemoprevention.
Description
Other Available Sources
Keywords
Articles, Breast Diseases: Benign & Malignant, Cancer Therapeutics, Clinical Nutrition, Diabetes & Obesity, Endocrine & Metabolic Pharmacology, Gastrointestinal Cancers, Genitourinary Cancers, Immunopharmacology & Hematologic Pharmacology, Menopause & Post-Reproductive Women's Health, Preventive Medicine, Toxicology, Cancer, chemoprevention, aspirin, nutrients, supplements, antiestrogens, antiandrogens, SERMs, aromatase inhibitors, vaccines, HBV, HPV
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service